Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients Webcast Jul 10, 2018
Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz Dec 5, 2017
Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies Jul 13, 2017
